The Rise Of Innovative Recharge-Free Neuromodulation Systems Enhance Patient Convenience And Therapy Adherence Is Influencing The Sacral Nerve Stimulation Devices Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Sacral Nerve Stimulation Devices Market Projected To Reach By 2030?
The sacral nerve stimulation devices market has seen rapid expansion in recent years. It is projected to expand from $1.48 billion in 2025 to $1.65 billion in 2026, maintaining a compound annual growth rate (CAGR) of 11.5%. Historically, this growth has been fueled by factors such as the increasing prevalence of urinary incontinence, a growing geriatric population, advancements in neuromodulation technology, broader clinical acceptance of nerve stimulation therapies, and the expansion of urology specialty services.
The sacral nerve stimulation devices market is poised for substantial growth in the upcoming years. It is projected to expand to $2.54 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 11.4%. This anticipated growth is driven by the increasing embrace of smart implantable devices, the rising demand for sustained continence management, the proliferation of outpatient neuromodulation procedures, a growing emphasis on personalized neurological therapies, and increased financial contributions to bioelectronic medicine. Prominent trends throughout this period include the rising adoption of implantable neuromodulation devices, an increasing need for minimally invasive bladder control treatments, the expanding integration of programmable stimulation technologies, the broadening availability of long-term neurological therapy solutions, and an enhanced focus on tailoring therapies to individual patients.
Access Your Free Sample Report For In-Depth Market Analysis:
What Leading Drivers Are Supporting The Sacral Nerve Stimulation Devices Market Expansion?
The future expansion of the sacral nerve stimulation devices market is anticipated to be driven by the growing occurrence of urological disorders. These conditions encompass a broad spectrum of ailments impacting the urinary tract, kidneys, bladder, and prostate, varying in duration from acute to chronic. Urological disorders can originate from diverse causes, affecting both the urinary and reproductive organs. Additionally, lifestyle habits such as poor dietary choices, dehydration, and insufficient exercise, can contribute to the development of kidney stones, a painful ailment affecting the urinary tract. Sacral nerve stimulation devices provide a minimally invasive treatment option that can effectively manage urological disorders like urinary and fecal incontinence. For instance, data from April 2024, shared by the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based healthcare company, revealed that on average each year, 651,446 individuals aged 65 and older (212,875 men and 438,572 women) received a new diagnosis of some form of urinary incontinence. Consequently, the increasing prevalence of urological disorders is expected to fuel the growth of the sacral nerve stimulation devices market.
How Is The Sacral Nerve Stimulation Devices Market Segmented Across Different Segment Categories?
The sacral nerve stimulation devices market covered in this report is segmented –
1) By Technology Modality: Implantable Sacral Neuromodulation, External Sacral Neuromodulation
2) By Product: External Sacral Nerve Stimulation Devices, Implantable Sacral Nerve Stimulation Devices
3) By Age Group: Pediatrics, Adults, Geriatrics
4) By Application: Urinary Incontinence, Fecal Incontinence, Bowel Dysfunction, Other Applications
5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Subsegments:
1) By Implantable Sacral Neuromodulation: Rechargeable Implantable SNS Systems, Non-Rechargeable Implantable SNS Systems
2) By External Sacral Neuromodulation: Transcutaneous Sacral Neuromodulation Systems, Wearable External Neuromodulation Devices
What Emerging Trends Are Seen In The Sacral Nerve Stimulation Devices Market?
Leading companies active in the Sacral Nerve Stimulation (SNS) devices market are concentrating on developing sophisticated solutions, like sacral neuromodulation systems that eliminate the need for recharging, to enhance convenience for patients and encourage adherence to treatment. Recharge-free sacral neuromodulation systems function as implantable devices that stimulate the sacral nerves to treat bladder and bowel dysfunction without necessitating regular battery recharges. As an illustration, in January 2025, Medtronic PLC, an Ireland-based medical technology firm, obtained FDA approval in India for its InterStim X Sacral Neuromodulation (SNM) system, which addresses bladder and bowel control issues such as overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. These systems are equipped with a proprietary fifth-generation battery that delivers over 10 years of therapy without recharging, potentially extending up to 15 years in low-energy configurations. It also incorporates a smart programmer, resembling a smartphone, allowing patients to independently adjust up to 11 therapy settings discreetly, whether at home or on the move. Furthermore, the system supports SureScan MRI technology, enabling patients to safely undergo full-body 1.5T and 3T MRI scans, with the MRI mode easily controlled by the patient under the guidance of a physician.
Which Organizations Play A Role In The Sacral Nerve Stimulation Devices Market Landscape?
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Neuspera Medical, Coloplast Group, Medtronic Neurovascular, NeuroPace Inc., Aleva Neurotherapeutics, LivaNova Neuromodulation, Nalu Medical, SetPoint Medical, NeuroSigma Inc., Saluda Medical, Soterix Medical, Inspire Medical Systems Inc., Synapse Biomedical Inc., Bioinduction Ltd
Get The Full Sacral Nerve Stimulation Devices Market Report:
Which Region Accounts For The Largest Portion Of The Sacral Nerve Stimulation Devices Market?
North America was the largest region in the sacral nerve stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Sacral Nerve Stimulation Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Sacral Nerve Stimulation Devices Market 2026, By The Business Research Company
Electrical Stimulation Devices Market Report 2026
Spinal Cord Stimulation Market Report 2026
https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report
Neurostimulation Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
